{
  "url": "https://openlegislation.uk/medicines-for-human-use-prescribing-order-2005/article-8",
  "json_url": "https://openlegislation.uk/medicines-for-human-use-prescribing-order-2005/article-8.json",
  "legislation": "uksi/2005/765",
  "legislation_title": "The Medicines for Human Use (Prescribing) Order 2005",
  "legislation_url": "https://openlegislation.uk/medicines-for-human-use-prescribing-order-2005",
  "path": "article/8",
  "kind": "article",
  "number": "8",
  "heading": "Amendment of Schedule 5 of the POM Order",
  "text": "In the table in Schedule 5 to the POM Order (exemption from restrictions on sale or supply), in paragraph 5 of Part I, in column 2, in sub-paragraph (c)—\n(a) omit “Atropine sulphate”, “Bethanecol chloride”, and “Carbachol”;\n(b) after “Cyclopentolate hydrochloride” insert “Fusidic Acid”; and\n(c) omit “Homatrophine hydrobromide”, “Naphazoline hydrochloride”, “Naphazoline Nitrate”, “Physostigmine salicylate”, “Philocarpine hydrochloride”, and Philocarpine nitrate”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2005/765/article/8",
    "retrieved_at": "2026-10-29T05:03:14.406634+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}